![Omega Therapeutics, Inc. logo](/logos/OMGA.webp)
Omega Therapeutics, Inc.
NASDAQ:OMGA
Overview | Financials
Company Name | Omega Therapeutics, Inc. |
Symbol | OMGA |
Currency | USD |
Price | 1.22 |
Market Cap | 67,289,100 |
Dividend Yield | 0% |
52-week-range | 1.22 - 6.3 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Mahesh Karande |
Website | https://www.omegatherapeutics.com |
An error occurred while fetching data.
About Omega Therapeutics, Inc.
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-regulate the expression of HNF4a,
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD